RxDoctor Payments Data

Miguel Lorenzo Litao, MD

Vascular Neurology · Bangor, MENPI 1811332836

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,907 of the $5,457 with a category attached, or 89.9%. 8 manufacturers reported payments, led by Imperative Care, Inc at 32.8% of the total. Reporting peaked in 2019 at $1,853 and has fallen 62.2% since, to $701 in 2025.

$5,457in general payments, 2019–2025

Across 76 payments — averaging $71.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Imperative Care, Inc$2K
  • Penumbra, Inc.$2K
  • Medtronic$867
  • Stryker$777
  • Qapel Medical Inc$300
  • Balt USA, LLC$173
  • plus $48 from 2 others
$25,000in ownership & investment interests, 2019–2025

Across 2 payments — averaging $12,500 each. An ownership or investment interest held by the physician or an immediate family member.

  • Agile Devices, Inc.$25K

What the payments were for

  • Travel & lodging$54910%
  • Food & beverage$4,90790%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Imperative Care, Inc24$1,789
Penumbra, Inc.12$1,502
Medtronic(2 entities)23$867
Stryker12$777
Qapel Medical Inc2$300
Balt USA, LLC1$173
BD1$32
Microvention, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular neurology providers in Maineto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$32,732
Medicare patients
109
Services billed
198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular neurology in Bangor

Where these figures come from

Is this you, or does something look wrong? →